Միելոդիսպլաստիկ համախտանիշ (Armenian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Միելոդիսպլաստիկ համախտանիշ" in Armenian language version.

refsWebsite

Global rank Armenian rank

27nih.gov

4^th place

3^rd place

18doi.org

2^nd place

4^th place

4lecturio.com

5,619^th place

low place

4worldcat.org

5^th place

10^th place

4semanticscholar.org

11^th place

428^th place

2web.archive.org

1^st place

1cancer.gov

1,684^th place

184^th place

1books.google.com

3^rd place

17^th place

1archive.org

6^th place

1harvard.edu

18^th place

38^th place

1biomedcentral.com

2,747^th place

793^rd place

1elsevier.com

610^th place

357^th place

1google.com

163^rd place

169^th place

archive.org

Bunn HF (November 1986). «5q- and disordered haematopoiesis». Clinics in Haematology. 15 (4): 1023–35. PMID 3552346.

biomedcentral.com

jhoonline.biomedcentral.com

Kotla, Venumadhav; Goel, Swati; Nischal, Sangeeta; Heuck, Christoph; Vivek, Kumar; Das, Bhaskar; Verma, Amit (2009-12). «Mechanism of action of lenalidomide in hematological malignancies». Journal of Hematology & Oncology (անգլերեն). 2 (1): 36. doi:10.1186/1756-8722-2-36. ISSN 1756-8722. PMC 2736171. PMID 19674465.{{cite journal}}: CS1 սպաս․ PMC format (link) CS1 սպաս․ չպիտակված ազատ DOI (link)

books.google.com

Hong WK, Holland JF (2010). Holland-Frei Cancer Medicine 8 (անգլերեն) (8 ed.). PMPH-USA. էջ 1544. ISBN 9781607950141. Արխիվացված օրիգինալից 2016 թ․ հոկտեմբերի 27-ին.

cancer.gov

«Myelodysplastic Syndromes Treatment (PDQ®) – Patient Version». NCI. 2015 թ․ օգոստոսի 12. Արխիվացված է օրիգինալից 2016 թ․ հոկտեմբերի 5-ին. Վերցված է 2016 թ․ հոկտեմբերի 27-ին.

doi.org

Germing U, Kobbe G, Haas R, Gattermann N (November 2013). «Myelodysplastic syndromes: diagnosis, prognosis, and treatment». Deutsches Ärzteblatt International. 110 (46): 783–90. doi:10.3238/arztebl.2013.0783. PMC 3855821. PMID 24300826.
Patnaik, Mrinal M.; Lasho, Terra (2020 թ․ դեկտեմբերի 4). «Evidence-Based Minireview: Myelodysplastic syndrome/myeloproliferative neoplasm overlap syndromes: a focused review». Hematology. 2020 (1): 460–464. doi:10.1182/hematology.2020000163. ISSN 1520-4391. PMC 7727594. PMID 33275673.
Iwanaga M, Hsu WL, Soda M, Takasaki Y, Tawara M, Joh T, և այլք: (February 2011). «Risk of myelodysplastic syndromes in people exposed to ionizing radiation: a retrospective cohort study of Nagasaki atomic bomb survivors». Journal of Clinical Oncology. 29 (4): 428–34. doi:10.1200/JCO.2010.31.3080. PMID 21149671.
Dokal, Inderjeet; Vulliamy, Tom (August 2010). «Inherited bone marrow failure syndromes». Haematologica. 95 (8): 1236–1240. doi:10.3324/haematol.2010.025619. ISSN 0390-6078. PMC 2913069. PMID 20675743.
Bejar, Rafael (December 2018). «What biologic factors predict for transformation to AML?». Best Practice & Research. Clinical Haematology. 31 (4): 341–345. doi:10.1016/j.beha.2018.10.002. ISSN 1532-1924. PMID 30466744. S2CID 53712886.
Wolach, O; Stone, R. M. (2015). «How I treat mixed-phenotype acute leukemia». Blood. 125 (16): 2477–85. doi:10.1182/blood-2014-10-551465. PMID 25605373.
Cazzola M, Invernizzi R, Bergamaschi G, Levi S, Corsi B, Travaglino E, և այլք: (March 2003). «Mitochondrial ferritin expression in erythroid cells from patients with sideroblastic anemia». Blood. 101 (5): 1996–2000. doi:10.1182/blood-2002-07-2006. PMID 12406866. S2CID 5729203.
Van den Berghe H, Cassiman JJ, David G, Fryns JP, Michaux JL, Sokal G (October 1974). «Distinct haematological disorder with deletion of long arm of no. 5 chromosome». Nature. 251 (5474): 437–38. Bibcode:1974Natur.251..437V. doi:10.1038/251437a0. PMID 4421285. S2CID 4286311.
List A, Kurtin S, Roe DJ, Buresh A, Mahadevan D, Fuchs D, և այլք: (February 2005). «Efficacy of lenalidomide in myelodysplastic syndromes». The New England Journal of Medicine. 352 (6): 549–57. doi:10.1056/NEJMoa041668. PMID 15703420.
Kotla, Venumadhav; Goel, Swati; Nischal, Sangeeta; Heuck, Christoph; Vivek, Kumar; Das, Bhaskar; Verma, Amit (2009-12). «Mechanism of action of lenalidomide in hematological malignancies». Journal of Hematology & Oncology (անգլերեն). 2 (1): 36. doi:10.1186/1756-8722-2-36. ISSN 1756-8722. PMC 2736171. PMID 19674465.{{cite journal}}: CS1 սպաս․ PMC format (link) CS1 սպաս․ չպիտակված ազատ DOI (link)
Molenaar RJ, Radivoyevitch T, Maciejewski JP, van Noorden CJ, Bleeker FE (December 2014). «The driver and passenger effects of isocitrate dehydrogenase 1 and 2 mutations in oncogenesis and survival prolongation». Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1846 (2): 326–41. doi:10.1016/j.bbcan.2014.05.004. PMID 24880135.
Molenaar RJ, Thota S, Nagata Y, Patel B, Clemente M, Przychodzen B, և այլք: (November 2015). «Clinical and biological implications of ancestral and non-ancestral IDH1 and IDH2 mutations in myeloid neoplasms». Leukemia. 29 (11): 2134–42. doi:10.1038/leu.2015.91. PMC 5821256. PMID 25836588.
Crispino JD, Horwitz MS (April 2017). «GATA factor mutations in hematologic disease». Blood. 129 (15): 2103–10. doi:10.1182/blood-2016-09-687889. PMC 5391620. PMID 28179280.
Hirabayashi S, Wlodarski MW, Kozyra E, Niemeyer CM (August 2017). «Heterogeneity of GATA2-related myeloid neoplasms». International Journal of Hematology. 106 (2): 175–82. doi:10.1007/s12185-017-2285-2. PMID 28643018.
Bhatnagar N, Nizery L, Tunstall O, Vyas P, Roberts I (October 2016). «Transient Abnormal Myelopoiesis and AML in Down Syndrome: an Update». Current Hematologic Malignancy Reports. 11 (5): 333–41. doi:10.1007/s11899-016-0338-x. PMC 5031718. PMID 27510823.
Seewald L, Taub JW, Maloney KW, McCabe ER (September 2012). «Acute leukemias in children with Down syndrome». Molecular Genetics and Metabolism. 107 (1–2): 25–30. doi:10.1016/j.ymgme.2012.07.011. PMID 22867885.
Foran, James M.; Shammo, Jamile M. (2012-07). «Clinical Presentation, Diagnosis, and Prognosis of Myelodysplastic Syndromes». The American Journal of Medicine (անգլերեն). 125 (7): S6–S13. doi:10.1016/j.amjmed.2012.04.015.
Huff JD, Keung YK, Thakuri M, Beaty MW, Hurd DD, Owen J, Molnár I (July 2007). «Copper deficiency causes reversible myelodysplasia». American Journal of Hematology. 82 (7): 625–30. doi:10.1002/ajh.20864. PMID 17236184. S2CID 44398996.

elsevier.com

linkinghub.elsevier.com

Foran, James M.; Shammo, Jamile M. (2012-07). «Clinical Presentation, Diagnosis, and Prognosis of Myelodysplastic Syndromes». The American Journal of Medicine (անգլերեն). 125 (7): S6–S13. doi:10.1016/j.amjmed.2012.04.015.

google.com

«Rudhiram Hematology Clinic - Google Search». www.google.com. Վերցված է 2022 թ․ փետրվարի 3-ին.

harvard.edu

ui.adsabs.harvard.edu

Van den Berghe H, Cassiman JJ, David G, Fryns JP, Michaux JL, Sokal G (October 1974). «Distinct haematological disorder with deletion of long arm of no. 5 chromosome». Nature. 251 (5474): 437–38. Bibcode:1974Natur.251..437V. doi:10.1038/251437a0. PMID 4421285. S2CID 4286311.

lecturio.com

«Anemia: Overview». The Lecturio Medical Concept Library. Վերցված է 2021 թ․ օգոստոսի 15-ին.
«Neutropenia». The Lecturio Medical Concept Library. Վերցված է 2021 թ․ օգոստոսի 15-ին.
«Thrombocytopenia». The Lecturio Medical Concept Library. Վերցված է 2021 թ․ օգոստոսի 15-ին.
«Myelodysplastic Syndromes». The Lecturio Medical Concept Library. Վերցված է 2021 թ․ օգոստոսի 11-ին.

nih.gov

pubmed.ncbi.nlm.nih.gov

Germing U, Kobbe G, Haas R, Gattermann N (November 2013). «Myelodysplastic syndromes: diagnosis, prognosis, and treatment». Deutsches Ärzteblatt International. 110 (46): 783–90. doi:10.3238/arztebl.2013.0783. PMC 3855821. PMID 24300826.
Patnaik, Mrinal M.; Lasho, Terra (2020 թ․ դեկտեմբերի 4). «Evidence-Based Minireview: Myelodysplastic syndrome/myeloproliferative neoplasm overlap syndromes: a focused review». Hematology. 2020 (1): 460–464. doi:10.1182/hematology.2020000163. ISSN 1520-4391. PMC 7727594. PMID 33275673.
Iwanaga M, Hsu WL, Soda M, Takasaki Y, Tawara M, Joh T, և այլք: (February 2011). «Risk of myelodysplastic syndromes in people exposed to ionizing radiation: a retrospective cohort study of Nagasaki atomic bomb survivors». Journal of Clinical Oncology. 29 (4): 428–34. doi:10.1200/JCO.2010.31.3080. PMID 21149671.
Dokal, Inderjeet; Vulliamy, Tom (August 2010). «Inherited bone marrow failure syndromes». Haematologica. 95 (8): 1236–1240. doi:10.3324/haematol.2010.025619. ISSN 0390-6078. PMC 2913069. PMID 20675743.
Bejar, Rafael (December 2018). «What biologic factors predict for transformation to AML?». Best Practice & Research. Clinical Haematology. 31 (4): 341–345. doi:10.1016/j.beha.2018.10.002. ISSN 1532-1924. PMID 30466744. S2CID 53712886.
Rasel, Mohammad; Mahboobi, Sohail K. (2022), «Transfusion Iron Overload», StatPearls, Treasure Island (FL): StatPearls Publishing, PMID 32965817, Վերցված է 2022-02-03-ին
Wolach, O; Stone, R. M. (2015). «How I treat mixed-phenotype acute leukemia». Blood. 125 (16): 2477–85. doi:10.1182/blood-2014-10-551465. PMID 25605373.
Cazzola M, Invernizzi R, Bergamaschi G, Levi S, Corsi B, Travaglino E, և այլք: (March 2003). «Mitochondrial ferritin expression in erythroid cells from patients with sideroblastic anemia». Blood. 101 (5): 1996–2000. doi:10.1182/blood-2002-07-2006. PMID 12406866. S2CID 5729203.
Bunn HF (November 1986). «5q- and disordered haematopoiesis». Clinics in Haematology. 15 (4): 1023–35. PMID 3552346.
Van den Berghe H, Cassiman JJ, David G, Fryns JP, Michaux JL, Sokal G (October 1974). «Distinct haematological disorder with deletion of long arm of no. 5 chromosome». Nature. 251 (5474): 437–38. Bibcode:1974Natur.251..437V. doi:10.1038/251437a0. PMID 4421285. S2CID 4286311.
List A, Kurtin S, Roe DJ, Buresh A, Mahadevan D, Fuchs D, և այլք: (February 2005). «Efficacy of lenalidomide in myelodysplastic syndromes». The New England Journal of Medicine. 352 (6): 549–57. doi:10.1056/NEJMoa041668. PMID 15703420.
Kotla, Venumadhav; Goel, Swati; Nischal, Sangeeta; Heuck, Christoph; Vivek, Kumar; Das, Bhaskar; Verma, Amit (2009-12). «Mechanism of action of lenalidomide in hematological malignancies». Journal of Hematology & Oncology (անգլերեն). 2 (1): 36. doi:10.1186/1756-8722-2-36. ISSN 1756-8722. PMC 2736171. PMID 19674465.{{cite journal}}: CS1 սպաս․ PMC format (link) CS1 սպաս․ չպիտակված ազատ DOI (link)
Molenaar RJ, Radivoyevitch T, Maciejewski JP, van Noorden CJ, Bleeker FE (December 2014). «The driver and passenger effects of isocitrate dehydrogenase 1 and 2 mutations in oncogenesis and survival prolongation». Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1846 (2): 326–41. doi:10.1016/j.bbcan.2014.05.004. PMID 24880135.
Molenaar RJ, Thota S, Nagata Y, Patel B, Clemente M, Przychodzen B, և այլք: (November 2015). «Clinical and biological implications of ancestral and non-ancestral IDH1 and IDH2 mutations in myeloid neoplasms». Leukemia. 29 (11): 2134–42. doi:10.1038/leu.2015.91. PMC 5821256. PMID 25836588.
Crispino JD, Horwitz MS (April 2017). «GATA factor mutations in hematologic disease». Blood. 129 (15): 2103–10. doi:10.1182/blood-2016-09-687889. PMC 5391620. PMID 28179280.
Hirabayashi S, Wlodarski MW, Kozyra E, Niemeyer CM (August 2017). «Heterogeneity of GATA2-related myeloid neoplasms». International Journal of Hematology. 106 (2): 175–82. doi:10.1007/s12185-017-2285-2. PMID 28643018.
Bhatnagar N, Nizery L, Tunstall O, Vyas P, Roberts I (October 2016). «Transient Abnormal Myelopoiesis and AML in Down Syndrome: an Update». Current Hematologic Malignancy Reports. 11 (5): 333–41. doi:10.1007/s11899-016-0338-x. PMC 5031718. PMID 27510823.
Seewald L, Taub JW, Maloney KW, McCabe ER (September 2012). «Acute leukemias in children with Down syndrome». Molecular Genetics and Metabolism. 107 (1–2): 25–30. doi:10.1016/j.ymgme.2012.07.011. PMID 22867885.
Huff JD, Keung YK, Thakuri M, Beaty MW, Hurd DD, Owen J, Molnár I (July 2007). «Copper deficiency causes reversible myelodysplasia». American Journal of Hematology. 82 (7): 625–30. doi:10.1002/ajh.20864. PMID 17236184. S2CID 44398996.

ncbi.nlm.nih.gov

Germing U, Kobbe G, Haas R, Gattermann N (November 2013). «Myelodysplastic syndromes: diagnosis, prognosis, and treatment». Deutsches Ärzteblatt International. 110 (46): 783–90. doi:10.3238/arztebl.2013.0783. PMC 3855821. PMID 24300826.
Patnaik, Mrinal M.; Lasho, Terra (2020 թ․ դեկտեմբերի 4). «Evidence-Based Minireview: Myelodysplastic syndrome/myeloproliferative neoplasm overlap syndromes: a focused review». Hematology. 2020 (1): 460–464. doi:10.1182/hematology.2020000163. ISSN 1520-4391. PMC 7727594. PMID 33275673.
Dokal, Inderjeet; Vulliamy, Tom (August 2010). «Inherited bone marrow failure syndromes». Haematologica. 95 (8): 1236–1240. doi:10.3324/haematol.2010.025619. ISSN 0390-6078. PMC 2913069. PMID 20675743.
Rasel, Mohammad; Mahboobi, Sohail K. (2022), «Transfusion Iron Overload», StatPearls, Treasure Island (FL): StatPearls Publishing, PMID 32965817, Վերցված է 2022-02-03-ին
Kotla, Venumadhav; Goel, Swati; Nischal, Sangeeta; Heuck, Christoph; Vivek, Kumar; Das, Bhaskar; Verma, Amit (2009-12). «Mechanism of action of lenalidomide in hematological malignancies». Journal of Hematology & Oncology (անգլերեն). 2 (1): 36. doi:10.1186/1756-8722-2-36. ISSN 1756-8722. PMC 2736171. PMID 19674465.{{cite journal}}: CS1 սպաս․ PMC format (link) CS1 սպաս․ չպիտակված ազատ DOI (link)
Molenaar RJ, Thota S, Nagata Y, Patel B, Clemente M, Przychodzen B, և այլք: (November 2015). «Clinical and biological implications of ancestral and non-ancestral IDH1 and IDH2 mutations in myeloid neoplasms». Leukemia. 29 (11): 2134–42. doi:10.1038/leu.2015.91. PMC 5821256. PMID 25836588.
Crispino JD, Horwitz MS (April 2017). «GATA factor mutations in hematologic disease». Blood. 129 (15): 2103–10. doi:10.1182/blood-2016-09-687889. PMC 5391620. PMID 28179280.
Bhatnagar N, Nizery L, Tunstall O, Vyas P, Roberts I (October 2016). «Transient Abnormal Myelopoiesis and AML in Down Syndrome: an Update». Current Hematologic Malignancy Reports. 11 (5): 333–41. doi:10.1007/s11899-016-0338-x. PMC 5031718. PMID 27510823.

semanticscholar.org

api.semanticscholar.org

Bejar, Rafael (December 2018). «What biologic factors predict for transformation to AML?». Best Practice & Research. Clinical Haematology. 31 (4): 341–345. doi:10.1016/j.beha.2018.10.002. ISSN 1532-1924. PMID 30466744. S2CID 53712886.
Cazzola M, Invernizzi R, Bergamaschi G, Levi S, Corsi B, Travaglino E, և այլք: (March 2003). «Mitochondrial ferritin expression in erythroid cells from patients with sideroblastic anemia». Blood. 101 (5): 1996–2000. doi:10.1182/blood-2002-07-2006. PMID 12406866. S2CID 5729203.
Van den Berghe H, Cassiman JJ, David G, Fryns JP, Michaux JL, Sokal G (October 1974). «Distinct haematological disorder with deletion of long arm of no. 5 chromosome». Nature. 251 (5474): 437–38. Bibcode:1974Natur.251..437V. doi:10.1038/251437a0. PMID 4421285. S2CID 4286311.
Huff JD, Keung YK, Thakuri M, Beaty MW, Hurd DD, Owen J, Molnár I (July 2007). «Copper deficiency causes reversible myelodysplasia». American Journal of Hematology. 82 (7): 625–30. doi:10.1002/ajh.20864. PMID 17236184. S2CID 44398996.

web.archive.org

«Myelodysplastic Syndromes Treatment (PDQ®) – Patient Version». NCI. 2015 թ․ օգոստոսի 12. Արխիվացված է օրիգինալից 2016 թ․ հոկտեմբերի 5-ին. Վերցված է 2016 թ․ հոկտեմբերի 27-ին.
Hong WK, Holland JF (2010). Holland-Frei Cancer Medicine 8 (անգլերեն) (8 ed.). PMPH-USA. էջ 1544. ISBN 9781607950141. Արխիվացված օրիգինալից 2016 թ․ հոկտեմբերի 27-ին.

worldcat.org

Patnaik, Mrinal M.; Lasho, Terra (2020 թ․ դեկտեմբերի 4). «Evidence-Based Minireview: Myelodysplastic syndrome/myeloproliferative neoplasm overlap syndromes: a focused review». Hematology. 2020 (1): 460–464. doi:10.1182/hematology.2020000163. ISSN 1520-4391. PMC 7727594. PMID 33275673.
Dokal, Inderjeet; Vulliamy, Tom (August 2010). «Inherited bone marrow failure syndromes». Haematologica. 95 (8): 1236–1240. doi:10.3324/haematol.2010.025619. ISSN 0390-6078. PMC 2913069. PMID 20675743.
Bejar, Rafael (December 2018). «What biologic factors predict for transformation to AML?». Best Practice & Research. Clinical Haematology. 31 (4): 341–345. doi:10.1016/j.beha.2018.10.002. ISSN 1532-1924. PMID 30466744. S2CID 53712886.
Kotla, Venumadhav; Goel, Swati; Nischal, Sangeeta; Heuck, Christoph; Vivek, Kumar; Das, Bhaskar; Verma, Amit (2009-12). «Mechanism of action of lenalidomide in hematological malignancies». Journal of Hematology & Oncology (անգլերեն). 2 (1): 36. doi:10.1186/1756-8722-2-36. ISSN 1756-8722. PMC 2736171. PMID 19674465.{{cite journal}}: CS1 սպաս․ PMC format (link) CS1 սպաս․ չպիտակված ազատ DOI (link)